Effects of a standardized saffron extract (Safr'Inside™) on menopause-related symptoms: a randomised, double-blind, placebo-controlled trial in perimenopausal women
In a randomized, double-blind, placebo-controlled trial involving 104 perimenopausal women, a 12-week treatment with a standardized saffron extract (Safr'Inside™) significantly reduced the severity of menopausal symptoms, particularly psychological and somatic disturbances, compared to placebo.